Herausgegeben von: Heidrun Flaadt Cervini

Dr. Heidrun Flaadt Cervini studied Biology at the University of Constance where she also completed her PhD. After her postdoctoral studies at Ecole Normale Supérieure in Paris, she attended Management Education in Zurich. She then served as COO of Diagene, a spin-off company at University of Basel. During that time, the company completed the first capital round. Driven by her interest for technology transfer she took over a position at the Office of Technology Transfer (OTT) at the University of Basel. In 2005, she started to build up a new OTT at EMPA in Dübendorf that she headed until end of 2007. In 2008, she moved to Ticino to join her husband and received a mandate from the Università della Svizzera italiana in Lugano to create new Executive Programs in the field of bio- and medtech entrepreneurship. Among others, she developed and implemented the BioBusiness, MedTech Business and eHealth Business program. Heidrun Flaadt Cervini is now the director of CASE BioMed, Center of Advanced Studies on Entrepreneurship in Biomedicine at USI. Heidrun Flaadt is also one of 16 Women in Healthcare Innovation 2021. The award was presented to her by the Innovation Office of the University of Basel (in collaboration with Impact Hub Basel, Healthcare Businesswomen Association, WomenMatters and WEHub) for her work as director of the Center of Advanced Studies on Entrepreneurship in BioMedicine (CASE BioMed) at the Faculty of Biomedical Sciences, Università della Svizzera italiana and her significant contribution to innovation. She has been on the advisory board of Swiss Healthcare Startups since 2024.